George Amato

Title: George Amato: Innovator in Cannabinoid Research

Introduction

George Amato is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of cannabinoid research, particularly through his innovative patent work. His expertise and dedication to advancing medical science have positioned him as a key figure in his area of specialization.

Latest Patents

George Amato holds a patent for "Indazole derivatives as cannabinoid receptor partial agonists." This patent includes peripheral partial agonists of one or more CB receptors, which modulate CB1, both with and without CB2 selectivity. The compounds described in this patent may be useful in treating diseases and disorders mediated by a CB-signaling pathway. These include, but are not limited to, pain, gastrointestinal disorders, metabolic disorders, and liver disorders such as alcoholic steatohepatitis or nonalcoholic steatohepatitis (NASH). He has 1 patent to his name.

Career Highlights

George Amato is associated with the Research Triangle Institute, where he applies his knowledge and skills to further research in cannabinoid applications. His work has the potential to impact various medical fields significantly.

Collaborations

Some of his notable coworkers include Rangan Maitra and Scott P Runyon. Their collaborative efforts contribute to the advancement of research and innovation in cannabinoid therapies.

Conclusion

George Amato's contributions to cannabinoid research through his patent work exemplify his commitment to improving medical treatments. His innovative approach and collaboration with other experts in the field continue to pave the way for future advancements.